Dicerna Pharmaceuticals, Inc. (DRNA) Posts Q1 Loss of $1.02/Share

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) reported Q1 EPS of ($1.02), $0.50 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Dicerna Pharmaceuticals, Inc. (DRNA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Logistic Properties of the Americas (LPA) Reports Q2 results
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02